Indigo BioAutomation, Inc.

Indigo BioAutomation develops laboratory automation software and data analytics platforms for clinical and life science laboratories. The company's primary offerings are ASCENT, a unified platform for liquid chromatography, gas chromatography, and mass spectrometry (LC/GC-MS/MS) workflow automation and data analysis, and ARQ, a PCR data analysis and automation solution for real-time and quantitative PCR (RT/qPCR) assays. Both products are delivered as SaaS (software-as-a-service) systems, enabling remote access and multi-instrument integration within a single quality framework aligned to laboratory SOPs. ASCENT and ARQ employ advanced algorithms and machine learning to automate complex data interpretation, enable exception-based review ("Releview"), and streamline high-throughput testing workflows. The platform integrates sample tracking, instrument data, and reporting to reduce manual review burden and accelerate turnaround times in clinical diagnostics and research settings. Indigo serves independent diagnostic laboratories, reference labs, test manufacturers, hospital laboratories, and academic medical centers, including Mayo Clinic, Duke Health, ARUP Laboratories, University of Washington, and numerous clinical diagnostic companies. The company emphasizes unified data governance, continuous validation monitoring, and AI-driven operational insights to support quality assurance and process improvement in complex analytical workflows.